Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2023 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer.
J Immunother Cancer. 2019 Sep 18;7(1):252. doi: 10.1186/s40425-019-0728-4.
J Immunother Cancer. 2019.
PMID: 31533840
Free PMC article.
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege.
Ager CR, Boda A, Rajapakshe K, Lea ST, Di Francesco ME, Jayaprakash P, Slay RB, Morrow B, Prasad R, Dean MA, Duffy CR, Coarfa C, Jones P, Curran MA.
Ager CR, et al. Among authors: slay rb.
J Immunother Cancer. 2021 Aug;9(8):e003246. doi: 10.1136/jitc-2021-003246.
J Immunother Cancer. 2021.
PMID: 34341132
Free PMC article.
Item in Clipboard
Cite
Cite